BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Asadi S, Roohbakhsh A, Shamsizadeh A, Fereidoni M, Kordijaz E, Moghimi A. The effect of intracerebroventricular administration of orexin receptor type 2 antagonist on pentylenetetrazol-induced kindled seizures and anxiety in rats. BMC Neurosci 2018;19:49. [PMID: 30103703 DOI: 10.1186/s12868-018-0445-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Iyer SH, Aggarwal A, Warren TJ, Hallgren J, Abel PW, Simeone TA, Simeone KA. Progressive cardiorespiratory dysfunction in Kv1.1 knockout mice may provide temporal biomarkers of pending sudden unexpected death in epilepsy (SUDEP): The contribution of orexin. Epilepsia 2020;61:572-88. [PMID: 32030748 DOI: 10.1111/epi.16434] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Gernert M, Feja M. Bypassing the Blood-Brain Barrier: Direct Intracranial Drug Delivery in Epilepsies. Pharmaceutics 2020;12:E1134. [PMID: 33255396 DOI: 10.3390/pharmaceutics12121134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Abraham ME, Gold J, Dondapati A, Gendreau J, Mammis A, Herschman Y. Intrathecal and intracerebroventricular dopamine for Parkinson's disease. Clin Neurol Neurosurg 2021;200:106374. [PMID: 33290887 DOI: 10.1016/j.clineuro.2020.106374] [Reference Citation Analysis]
4 Fernández-Teruel A, Tobeña A. Revisiting the role of anxiety in the initial acquisition of two-way active avoidance: pharmacological, behavioural and neuroanatomical convergence. Neurosci Biobehav Rev 2020;118:739-58. [PMID: 32916193 DOI: 10.1016/j.neubiorev.2020.08.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
5 Abounoori M, Maddah MM, Akbari E, Houshmand G, Ardeshiri MR. The Effect of Orexin Receptor Antagonism on Quinpirole-Induced Compulsive-Like Checking Behavior in Rats. Neurotox Res 2020;38:18-26. [PMID: 32207079 DOI: 10.1007/s12640-020-00196-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
6 Razavi BM, Farivar O, Etemad L, Hosseinzadeh H. Suvorexant, a Dual Orexin Receptor Antagonist, Protected Seizure through Interaction with GABAA and Glutamate Receptors. Iran J Pharm Res 2020;19:383-90. [PMID: 33224245 DOI: 10.22037/ijpr.2019.14688.12584] [Reference Citation Analysis]